首页 /研究 /Commentary: Neoadjuvant checkpoint inhibitors in resectable non–small cell lung cancer—Ready for prime time?
OTHER

Commentary: Neoadjuvant checkpoint inhibitors in resectable non–small cell lung cancer—Ready for prime time?

Boris Sepesi, Tina Cascone

发表年份
2019
引用次数
2
访问权限
开放获取

关键词

MedicineImmunotherapyLung cancerOncologyChemotherapyInternal medicineCancerRadiation therapyClinical trial

相关论文

查看 OTHER 分类全部论文